ArticleTranslational oncology2020

Oncogenic fusion protein FGFR2-PPHLN1: Requirements for biological activation, and efficacy of inhibitors.

Fangda Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.